APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sheep and Goat Pox Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sheep and Goat Pox Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchSheep and Goat Pox Vaccines Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Sheep and Goat Pox Vaccines Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Sheep and Goat Pox Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sheep and Goat Pox Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Sheep and Goat Pox Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sheep and Goat Pox Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sheep and Goat Pox Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sheep and Goat Pox Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sheep and Goat Pox Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sheep and Goat Pox Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sheep and Goat Pox Vaccines include Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd. and JOVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sheep and Goat Pox Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sheep and Goat Pox Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sheep and Goat Pox Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sheep and Goat Pox Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Sheep and Goat Pox Vaccines Segment by Company

Agrovet

Biopharma

Dollvet

FGBI - Federal Centre for Animal Health

Hester Biosciences Limited

Indian Immunologicals Limited

Institut Pasteur d'Algerie

Intervac (PVT) Ltd.

JOVAC

Vetal Company

Veterinary Research Institute

Tiankang Biopharmacuetical

Sheep and Goat Pox Vaccines Segment by Type

Attenuated Live Vaccines

Killed Vaccines

Sheep and Goat Pox Vaccines Segment by Application

Sheep

Goat

Sheep and Goat Pox Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sheep and Goat Pox Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sheep and Goat Pox Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sheep and Goat Pox Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sheep and Goat Pox Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sheep and Goat Pox Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sheep and Goat Pox Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sheep and Goat Pox Vaccines Industry Trends Table 2. Sheep and Goat Pox Vaccines Industry Drivers Table 3. Sheep and Goat Pox Vaccines Industry Opportunities and Challenges Table 4. Sheep and Goat Pox Vaccines Industry Restraints Table 5. Global Sheep and Goat Pox Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sheep and Goat Pox Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sheep and Goat Pox Vaccines Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Sheep and Goat Pox Vaccines Sales Market Share by Manufacturers Table 9. Global Sheep and Goat Pox Vaccines Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Sheep and Goat Pox Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sheep and Goat Pox Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sheep and Goat Pox Vaccines Manufacturers, Product Type & Application Table 13. Global Sheep and Goat Pox Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sheep and Goat Pox Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Attenuated Live Vaccines Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Sheep and Goat Pox Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Sheep and Goat Pox Vaccines Sales by Type (2021-2026) & (m units) Table 20. Global Sheep and Goat Pox Vaccines Sales by Type (2027-2032) & (m units) Table 21. Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Sheep and Goat Pox Vaccines Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Sheep and Goat Pox Vaccines Revenue by Type (2021-2026) & (m units) Table 25. Global Sheep and Goat Pox Vaccines Revenue by Type (2027-2032) & (m units) Table 26. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Sheep Table 29. Major Manufacturers of Goat Table 30. Global Sheep and Goat Pox Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 31. Global Sheep and Goat Pox Vaccines Sales by Application (2021-2026) & (m units) Table 32. Global Sheep and Goat Pox Vaccines Sales by Application (2027-2032) & (m units) Table 33. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Sheep and Goat Pox Vaccines Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 36. Global Sheep and Goat Pox Vaccines Revenue by Application (2021-2026) & (m units) Table 37. Global Sheep and Goat Pox Vaccines Revenue by Application (2027-2032) & (m units) Table 38. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Sheep and Goat Pox Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 41. Global Sheep and Goat Pox Vaccines Sales by Region (2021-2026) & (m units) Table 42. Global Sheep and Goat Pox Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Sheep and Goat Pox Vaccines Sales Forecasted by Region (2027-2032) & (m units) Table 44. Global Sheep and Goat Pox Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 46. North America Sheep and Goat Pox Vaccines Sales by Country (2021-2026) & (m units) Table 47. North America Sheep and Goat Pox Vaccines Sales by Country (2027-2032) & (m units) Table 48. Europe Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 49. Europe Sheep and Goat Pox Vaccines Sales by Country (2021-2026) & (m units) Table 50. Europe Sheep and Goat Pox Vaccines Sales by Country (2027-2032) & (m units) Table 51. Asia Pacific Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 52. Asia Pacific Sheep and Goat Pox Vaccines Sales by Country (2021-2026) & (m units) Table 53. Asia Pacific Sheep and Goat Pox Vaccines Sales by Country (2027-2032) & (m units) Table 54. South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 55. South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales by Country (2021-2026) & (m units) Table 56. South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales by Country (2027-2032) & (m units) Table 57. Global Sheep and Goat Pox Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Sheep and Goat Pox Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Sheep and Goat Pox Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Sheep and Goat Pox Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Sheep and Goat Pox Vaccines Revenue Market Share by Region (2027-2032) Table 62. Agrovet Company Information Table 63. Agrovet Business Overview Table 64. Agrovet Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Agrovet Sheep and Goat Pox Vaccines Product Portfolio Table 66. Agrovet Recent Development Table 67. Biopharma Company Information Table 68. Biopharma Business Overview Table 69. Biopharma Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Biopharma Sheep and Goat Pox Vaccines Product Portfolio Table 71. Biopharma Recent Development Table 72. Dollvet Company Information Table 73. Dollvet Business Overview Table 74. Dollvet Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Dollvet Sheep and Goat Pox Vaccines Product Portfolio Table 76. Dollvet Recent Development Table 77. FGBI - Federal Centre for Animal Health Company Information Table 78. FGBI - Federal Centre for Animal Health Business Overview Table 79. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolio Table 81. FGBI - Federal Centre for Animal Health Recent Development Table 82. Hester Biosciences Limited Company Information Table 83. Hester Biosciences Limited Business Overview Table 84. Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolio Table 86. Hester Biosciences Limited Recent Development Table 87. Indian Immunologicals Limited Company Information Table 88. Indian Immunologicals Limited Business Overview Table 89. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolio Table 91. Indian Immunologicals Limited Recent Development Table 92. Institut Pasteur d'Algerie Company Information Table 93. Institut Pasteur d'Algerie Business Overview Table 94. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolio Table 96. Institut Pasteur d'Algerie Recent Development Table 97. Intervac (PVT) Ltd. Company Information Table 98. Intervac (PVT) Ltd. Business Overview Table 99. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolio Table 101. Intervac (PVT) Ltd. Recent Development Table 102. JOVAC Company Information Table 103. JOVAC Business Overview Table 104. JOVAC Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. JOVAC Sheep and Goat Pox Vaccines Product Portfolio Table 106. JOVAC Recent Development Table 107. Vetal Company Company Information Table 108. Vetal Company Business Overview Table 109. Vetal Company Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Vetal Company Sheep and Goat Pox Vaccines Product Portfolio Table 111. Vetal Company Recent Development Table 112. Veterinary Research Institute Company Information Table 113. Veterinary Research Institute Business Overview Table 114. Veterinary Research Institute Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolio Table 116. Veterinary Research Institute Recent Development Table 117. Tiankang Biopharmacuetical Company Information Table 118. Tiankang Biopharmacuetical Business Overview Table 119. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolio Table 121. Tiankang Biopharmacuetical Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Sheep and Goat Pox Vaccines Distributors List Table 125. Sheep and Goat Pox Vaccines Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Sheep and Goat Pox Vaccines Product Image Figure 2. Global Sheep and Goat Pox Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sheep and Goat Pox Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Sheep and Goat Pox Vaccines Sales (2021-2032) & (m units) Figure 5. Global Sheep and Goat Pox Vaccines Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sheep and Goat Pox Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Attenuated Live Vaccines Image Figure 9. Killed Vaccines Image Figure 10. Global Sheep and Goat Pox Vaccines Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Sheep and Goat Pox Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Sheep and Goat Pox Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Sheep and Goat Pox Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Sheep Image Figure 17. Goat Image Figure 18. Global Sheep and Goat Pox Vaccines Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 19. Global Sheep and Goat Pox Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Sheep and Goat Pox Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 22. Global Sheep and Goat Pox Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 25. North America Sheep and Goat Pox Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 27. Canada Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 28. Mexico Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 29. Europe Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Sheep and Goat Pox Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 32. France Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 33. U.K. Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 34. Italy Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 35. Netherlands Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 36. Asia Pacific Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Sheep and Goat Pox Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 39. Japan Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 40. South Korea Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 41. Southeast Asia Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 42. India Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 43. Australia Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 44. South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 47. South Africa Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 48. Saudi Arabia Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 49. Turkey Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 50. Argentina Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 51. UAE Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 52. Egypt Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 53. Chile Sheep and Goat Pox Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 54. Global Sheep and Goat Pox Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Sheep and Goat Pox Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Sheep and Goat Pox Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Sheep and Goat Pox Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Sheep and Goat Pox Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Sheep and Goat Pox Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Sheep and Goat Pox Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Sheep and Goat Pox Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Live Vaccines
  • Killed Vaccines
Applications
  • Sheep
  • Goat
Companies covered
  • Agrovet
  • Biopharma
  • Dollvet
  • FGBI - Federal Centre for Animal Health
  • Hester Biosciences Limited
  • Indian Immunologicals Limited
  • Institut Pasteur d'Algerie
  • Intervac (PVT) Ltd.
  • JOVAC
  • Vetal Company
  • Veterinary Research Institute
  • Tiankang Biopharmacuetical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sheep and Goat Pox Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sheep and Goat Pox Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sheep and Goat Pox Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sheep and Goat Pox Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sheep and Goat Pox Vaccines Market Dynamics
  1. 2.1 Sheep and Goat Pox Vaccines Industry Trends
  2. 2.2 Sheep and Goat Pox Vaccines Industry Drivers
  3. 2.3 Sheep and Goat Pox Vaccines Industry Opportunities and Challenges
  4. 2.4 Sheep and Goat Pox Vaccines Industry Restraints
3 Sheep and Goat Pox Vaccines Market by Manufacturers
  1. 3.1 Global Sheep and Goat Pox Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sheep and Goat Pox Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sheep and Goat Pox Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sheep and Goat Pox Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sheep and Goat Pox Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sheep and Goat Pox Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Sheep and Goat Pox Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sheep and Goat Pox Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sheep and Goat Pox Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sheep and Goat Pox Vaccines Tier 1, Tier 2, and Tier 3
4 Sheep and Goat Pox Vaccines Market by Type
  1. 4.1 Sheep and Goat Pox Vaccines Type Introduction
  2. 4.1.1 Attenuated Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Sheep and Goat Pox Vaccines Sales by Type
  5. 4.2.1 Global Sheep and Goat Pox Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sheep and Goat Pox Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Sheep and Goat Pox Vaccines Revenue by Type
  9. 4.3.1 Global Sheep and Goat Pox Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2021-2032)
5 Sheep and Goat Pox Vaccines Market by Application
  1. 5.1 Sheep and Goat Pox Vaccines Application Introduction
  2. 5.1.1 Sheep
  3. 5.1.2 Goat
  4. 5.2 Global Sheep and Goat Pox Vaccines Sales by Application
  5. 5.2.1 Global Sheep and Goat Pox Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sheep and Goat Pox Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sheep and Goat Pox Vaccines Revenue by Application
  9. 5.3.1 Global Sheep and Goat Pox Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2021-2032)
6 Global Sheep and Goat Pox Vaccines Sales by Region
  1. 6.1 Global Sheep and Goat Pox Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sheep and Goat Pox Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Sheep and Goat Pox Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Sheep and Goat Pox Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sheep and Goat Pox Vaccines Revenue by Region
  1. 7.1 Global Sheep and Goat Pox Vaccines Revenue by Region
  2. 7.1.1 Global Sheep and Goat Pox Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sheep and Goat Pox Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Sheep and Goat Pox Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Sheep and Goat Pox Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sheep and Goat Pox Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sheep and Goat Pox Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sheep and Goat Pox Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sheep and Goat Pox Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sheep and Goat Pox Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Agrovet
  2. 8.1.1 Agrovet Company Information
  3. 8.1.2 Agrovet Business Overview
  4. 8.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agrovet Sheep and Goat Pox Vaccines Product Portfolio
  6. 8.1.5 Agrovet Recent Developments
  7. 8.2 Biopharma
  8. 8.2.1 Biopharma Company Information
  9. 8.2.2 Biopharma Business Overview
  10. 8.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biopharma Sheep and Goat Pox Vaccines Product Portfolio
  12. 8.2.5 Biopharma Recent Developments
  13. 8.3 Dollvet
  14. 8.3.1 Dollvet Company Information
  15. 8.3.2 Dollvet Business Overview
  16. 8.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dollvet Sheep and Goat Pox Vaccines Product Portfolio
  18. 8.3.5 Dollvet Recent Developments
  19. 8.4 FGBI - Federal Centre for Animal Health
  20. 8.4.1 FGBI - Federal Centre for Animal Health Company Information
  21. 8.4.2 FGBI - Federal Centre for Animal Health Business Overview
  22. 8.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolio
  24. 8.4.5 FGBI - Federal Centre for Animal Health Recent Developments
  25. 8.5 Hester Biosciences Limited
  26. 8.5.1 Hester Biosciences Limited Company Information
  27. 8.5.2 Hester Biosciences Limited Business Overview
  28. 8.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolio
  30. 8.5.5 Hester Biosciences Limited Recent Developments
  31. 8.6 Indian Immunologicals Limited
  32. 8.6.1 Indian Immunologicals Limited Company Information
  33. 8.6.2 Indian Immunologicals Limited Business Overview
  34. 8.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolio
  36. 8.6.5 Indian Immunologicals Limited Recent Developments
  37. 8.7 Institut Pasteur d'Algerie
  38. 8.7.1 Institut Pasteur d'Algerie Company Information
  39. 8.7.2 Institut Pasteur d'Algerie Business Overview
  40. 8.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolio
  42. 8.7.5 Institut Pasteur d'Algerie Recent Developments
  43. 8.8 Intervac (PVT) Ltd.
  44. 8.8.1 Intervac (PVT) Ltd. Company Information
  45. 8.8.2 Intervac (PVT) Ltd. Business Overview
  46. 8.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolio
  48. 8.8.5 Intervac (PVT) Ltd. Recent Developments
  49. 8.9 JOVAC
  50. 8.9.1 JOVAC Company Information
  51. 8.9.2 JOVAC Business Overview
  52. 8.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 JOVAC Sheep and Goat Pox Vaccines Product Portfolio
  54. 8.9.5 JOVAC Recent Developments
  55. 8.10 Vetal Company
  56. 8.10.1 Vetal Company Company Information
  57. 8.10.2 Vetal Company Business Overview
  58. 8.10.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vetal Company Sheep and Goat Pox Vaccines Product Portfolio
  60. 8.10.5 Vetal Company Recent Developments
  61. 8.11 Veterinary Research Institute
  62. 8.11.1 Veterinary Research Institute Company Information
  63. 8.11.2 Veterinary Research Institute Business Overview
  64. 8.11.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolio
  66. 8.11.5 Veterinary Research Institute Recent Developments
  67. 8.12 Tiankang Biopharmacuetical
  68. 8.12.1 Tiankang Biopharmacuetical Company Information
  69. 8.12.2 Tiankang Biopharmacuetical Business Overview
  70. 8.12.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolio
  72. 8.12.5 Tiankang Biopharmacuetical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sheep and Goat Pox Vaccines Value Chain Analysis
  2. 9.1.1 Sheep and Goat Pox Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sheep and Goat Pox Vaccines Production Mode & Process
  6. 9.2 Sheep and Goat Pox Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sheep and Goat Pox Vaccines Distributors
  9. 9.2.3 Sheep and Goat Pox Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst